The “CD22 Targeted Therapies Market, Approved Drug Sales, Technology Platforms & Clinical Trials Insight 2026” report has been added to ResearchAndMarkets.co… DUBLIN–(BUSI...
ESTEVE and TerSera Therapeutics LLC announced today that they have entered into an agreement in which ESTEVE will acquire TerSera’s Infusion Specialty Therap… BARCELONA & DEERFIELD, Ill....
EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, and President Donald J. Trump’s administration, today announce… BOSTON–(BUSINESS WIRE)–...
